Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by Scorpio2on Aug 25, 2022 5:15pm
381 Views
Post# 34921018

We are Very Close

We are Very Close We are very close to a pivotal turnaround from this engineered idiocy.

1) Idiot gap filled now, also
2) have a Bollinger Band crash today/tomorrow (that's a major buy signal for those that don't know),
3) insects crawling out from under rocks that think they can post negativity with a minimum level of intelligence)
4) stochastics approaching oversold levels setting up a launchpad for upward price action and
5) we are about to get fundamental news on our Phase 2 trial update and likely movement of the PR's to CR's at 270 days in the trial data, which will improve our efficacy numbers. 

If somebody doesn't buy the low tomorrow, I will buy more...maybe take out that 50,000 share offer at 0.295. Who's going to get it first?
<< Previous
Bullboard Posts
Next >>